Amarin Corp Plc (AMRN)

[1millman]

If I were short on this stock, I would cover first thing Monday morning. The August conference call will provide for some answers that longs have been waiting for. I see the pps rising over the next week leading up to the CC. Management will certainly guide forward and make mention of the patents that were allowed. We will probably see $9 leading up to the advisory board meeting in October and if all looks good from there, a steady rise to $12 leading up the the December decision date. If V is approved by the FDA for the lower indications, I see it spiking to $25 because BP will be tripping over themselves trying to get cuddly with AMRN.This coould be a $5B to $10B annual sales drug so do the math.